(Q36563903)

14 August 2017

Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma (English)

1 reference

14 August 2017

Rekha T Tripathi

1

1 reference

14 August 2017

Lance K Heilbrun

series ordinal

2

1 reference

14 August 2017

Vikash Jain

series ordinal

3

1 reference

14 August 2017

Ulka N Vaishampayan

series ordinal

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

14 August 2017

1 reference

14 August 2017

68

1 reference

14 August 2017

2

1 reference

14 August 2017

296-301

1 reference

14 August 2017

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.02.036

Rising incidence of renal cell cancer in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.02.036

The changing natural history of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.02.036

Racial disparity in incidence patterns and outcome of kidney cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.02.036

Impact of breast carcinoma on African-American women: the Detroit experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.02.036

Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.02.036

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.02.036

Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.02.036

Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.02.036

HLA phenotype and cytokine-induced tumor control in advanced renal cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.02.036

10.1016/J.UROLOGY.2006.02.036

7 January 2021

Identifiers

DOI

1 reference

14 August 2017

1 reference